Bristol-Myers Squibb
BMY
BMY
1,301 hedge funds and large institutions have $60.9B invested in Bristol-Myers Squibb in 2014 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 457 increasing their positions, 540 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.29% more ownership
Funds ownership: 71.56% → 71.84% (+0.29%)
0% more funds holding
Funds holding: 1,301 → 1,301 (0)
15% less repeat investments, than reductions
Existing positions increased: 457 | Existing positions reduced: 540
Holders
1,301
Holding in Top 10
43
Calls
$805M
Puts
$740M
Top Buyers
| 1 | +$741M | |
| 2 | +$249M | |
| 3 | +$210M | |
| 4 |
Jennison Associates
New York
|
+$180M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$156M |
Top Sellers
| 1 | -$618M | |
| 2 | -$306M | |
| 3 | -$181M | |
| 4 |
Renaissance Technologies
New York
|
-$112M |
| 5 |
IC
Institutional Capital
Chicago,
Illinois
|
-$109M |